| Association of liver abnormalities with in-hospital mortality in patients with COVID-19 Z Ding, G Li, L Chen, C Shu, J Song, W Wang, Y Wang, Q Chen, G Jin, ... Journal of hepatology 74 (6), 1295-1302, 2021 | 164 | 2021 |
| Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma Z Ding, G Jin, W Wang, W Chen, Y Wu, X Ai, L Chen, W Zhang, H Liang, ... Hepatology 60 (5), 1620-1636, 2014 | 106 | 2014 |
| Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling Z Ding, G Jin, H Liang, W Wang, W Chen, PK Datta, M Zhang, B Zhang, ... Cellular signalling 25 (10), 1981-1992, 2013 | 82 | 2013 |
| The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway J Song, Y Liu, F Liu, L Zhang, G Li, C Yuan, C Yu, X Lu, Q Liu, X Chen, ... Theranostics 11 (3), 996, 2021 | 68 | 2021 |
| Learning curve in robot-assisted laparoscopic liver resection P Zhu, W Liao, Z Ding, L Chen, W Zhang, B Zhang, X Chen Journal of Gastrointestinal Surgery 23 (9), 1778-1787, 2019 | 61 | 2019 |
| MicroRNA-630 suppresses tumor metastasis through the TGF-β-miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma W Chen, Z Zhang, Z Ding, H Liang, J Song, X Tan, J Wu, G Li, Z Zeng, ... Oncotarget 7 (16), 22674, 2016 | 58 | 2016 |
| Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma G Li, W Xu, L Zhang, T Liu, G Jin, J Song, J Wu, Y Wang, W Chen, ... EBioMedicine 47, 128-141, 2019 | 56 | 2019 |
| The roles of TIF1γ in cancer C Yu, Z Ding, H Liang, B Zhang, X Chen Frontiers in Oncology 9, 979, 2019 | 53 | 2019 |
| H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen‐Activated Protein Kinase–Dependent … Z Huang, L Chu, J Liang, X Tan, Y Wang, J Wen, J Chen, Y Wu, S Liu, ... Hepatology 74 (1), 214-232, 2021 | 52 | 2021 |
| Hyperbaric oxygen boosts PD‐1 antibody delivery and T cell infiltration for augmented immune responses against solid tumors X Liu, N Ye, S Liu, J Guan, Q Deng, Z Zhang, C Xiao, Z Ding, B Zhang, ... Advanced Science 8 (15), 2100233, 2021 | 51 | 2021 |
| Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review W Chen, G Li, Z Hu, P Zhu, B Zhang, Z Ding Medicine 98 (45), e17832, 2019 | 49 | 2019 |
| Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside Y Liu, Y Wang, S Sun, Z Chen, S Xiang, Z Ding, Z Huang, B Zhang Experimental hematology & oncology 11 (1), 97, 2022 | 44 | 2022 |
| Activin A induces growth arrest through a SMAD-dependent pathway in hepatic progenitor cells L Chen, W Zhang, H Liang, Q Zhou, Z Ding, H Yang, W Liu, Y Wu, Q Man, ... Cell Communication and Signaling 12, 1-14, 2014 | 43 | 2014 |
| Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy J Chen, Z Ding, S Li, S Liu, C Xiao, Z Li, B Zhang, X Chen, X Yang Theranostics 11 (3), 1345, 2021 | 40 | 2021 |
| Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation J Liang, G Li, J Liao, Z Huang, J Wen, Y Wang, Z Chen, G Cai, W Xu, ... Cell Death & Differentiation 29 (5), 988-1003, 2022 | 39 | 2022 |
| PTPRε acts as a metastatic promoter in hepatocellular carcinoma by facilitating recruitment of SMAD3 to TGF‐β receptor 1 Z Liao, L Chen, X Zhang, H Zhang, X Tan, K Dong, X Lu, H Zhu, Q Liu, ... Hepatology 72 (3), 997-1012, 2020 | 39 | 2020 |
| Clinical characteristics and risk factors for mortality in cancer patients with COVID-19 J Liang, G Jin, T Liu, J Wen, G Li, L Chen, W Wang, Y Wang, W Liao, ... Frontiers of Medicine 15, 264-274, 2021 | 36 | 2021 |
| CD2‐associated protein contributes to hepatitis C, virus propagation and steatosis by disrupting insulin signaling H Zhang, C Zhang, H Tang, S Gao, F Sun, Y Yang, W Zhou, Y Hu, C Ke, ... Hepatology 68 (5), 1710-1725, 2018 | 34 | 2018 |
| The emerging roles of IDO2 in cancer and its potential as a therapeutic target P Li, W Xu, F Liu, H Zhu, L Zhang, Z Ding, H Liang, J Song Biomedicine & Pharmacotherapy 137, 111295, 2021 | 33 | 2021 |
| TRIM proteins in hepatocellular carcinoma K Lu, Y Pan, Z Huang, H Liang, Z Ding, B Zhang Journal of biomedical science 29 (1), 69, 2022 | 30 | 2022 |
